Patents by Inventor Beth Rumberger

Beth Rumberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957661
    Abstract: This disclosure relates to JAK1 pathway inhibitors and their use in treating vitiligo.
    Type: Grant
    Filed: December 8, 2021
    Date of Patent: April 16, 2024
    Assignee: Incyte Corporation
    Inventors: Paul Smith, Kurt Andrew Brown, Michael D. Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos, Beth Rumberger
  • Publication number: 20230220478
    Abstract: Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo.
    Type: Application
    Filed: December 28, 2022
    Publication date: July 13, 2023
    Inventors: Michael D. Howell, Sherry Owens, Beth Rumberger, Huiqing Liu
  • Patent number: 11624751
    Abstract: Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: April 11, 2023
    Assignee: Incyte Corporation
    Inventors: Michael D. Howell, Sherry Owens, Beth Rumberger, Huiqing Liu
  • Publication number: 20220175731
    Abstract: This disclosure relates to JAK1 pathway inhibitors and their use in treating vitiligo.
    Type: Application
    Filed: December 8, 2021
    Publication date: June 9, 2022
    Inventors: Paul Smith, Kurt Andrew Brown, Michael D. Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos, Beth Rumberger
  • Publication number: 20200348313
    Abstract: Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo.
    Type: Application
    Filed: March 18, 2020
    Publication date: November 5, 2020
    Inventors: Michael D. Howell, Sherry Owens, Beth Rumberger, Huiqing Liu